Evidence map›Paper›PMID 32269380›Full record

ReviewNature reviews. Immunology2020

Modulation of regulatory T cell function and stability by co-inhibitory receptors.

Liliana E Lucca, Margarita Dominguez-Villar

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 116 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05423691 phase1recruitingnot on this mapstarted 2022, after this paper: background citation

Phase Ib, Open-label Study of Add on Therapy With CK0804 in Participants With Myelofibrosis, With Suboptimal Response to Ruxolitinib

TypeinterventionalSponsorCellenkos, Inc.Ran2022 to 2026Enrolled24ConditionsMyelofibrosisArmsCK0804
NCT05695521 phase1active not recruitingnot on this mapstarted 2023, after this paper: background citation

Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial

TypeinterventionalSponsorCellenkos, Inc.Ran2023 to 2027Enrolled66ConditionsAmyotrophic Lateral SclerosisArmsCK0803, Excipient
3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 1 synthesis or guideline pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Elevated ST2Arthritis research & therapy · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. TIM3-mediated differentiation of IL-10-producing CD25Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Exhausted and Senescent CD4Diagnostics (Basel, Switzerland) · 2025
    Article
  19. Review
  20. Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Liliana E LuccaDepartments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-5109-0128
Margarita Dominguez-VillarFaculty of Medicine, Imperial College London, London, UK. m.dominguez-villar@imperial.ac.uk.ORCID http://orcid.org/0000-0002-9719-0028
Imperial College London · GBYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory T (T

Indexed as

AnimalsAntineoplastic Agents, ImmunologicalAutoimmunityCostimulatory and Inhibitory T-Cell ReceptorsDrug Delivery SystemsHumansNeoplasmsT-Lymphocytes, RegulatoryAntineoplastic Agents, ImmunologicalCostimulatory and Inhibitory T-Cell Receptors

Identifiers

PMID32269380
OpenAlexW3015697300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.